Cronos Group Inc.
CRONNasdaq
$2.79
↑ +1.5%Jul 17 close · end-of-day
Price
1Y↑ +38.8%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.1B
Enterprise Value
$243.4M
P/E
—
P/S
6.7
P/B
1.0
EV/EBITDA
—
PEG
—
FCF Yield
2.5%
Dividend Yield
—
Revenue (TTM)
$159.5M
Net Income (TTM)
$4.7M
Free Cash Flow (TTM)
$26.5M
Gross Margin
42.7%
Operating Margin
-9.5%
Net Margin
3.0%
ROE
0.4%
ROIC
-4.8%
Debt / Equity
—
Net Cash
$821.9M
Return 1Y
+36.1%
Company profile
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for medical and adult-use markets.
- CEO
- Michael R. Gorenstein
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 450
- Headquarters
- Ontario
- Website
- thecronosgroup.com
Management & directors
- Buggy ShannonSee Remarks
- Doucet Terrence Gregory JosephSee Remarks
- Kenost Jared MatthewSee Remarks
- Wagner AdamSee remarks
- Weigensberg AryeSee Remarks
- Shlimak AnnaSee Remarks
- Gorenstein Michael RyanSee remarks below
- Jacobson Jeffrey DavidChief Growth Officer
Roles derived from SEC Form 4 filings.
Earnings
CRON Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$45.2M↑ +40.1%
Diluted EPS$0.04↑ +100.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $46.7M | $64.6M | $86.7M | $87.2M | $117.6M | $146.6M |
| Gross profit | -$25.8M | -$17.6M | $15.4M | $11.9M | $25.2M | $62.8M |
| Operating income | -$219.4M | -$292.0M | -$111.4M | -$84.8M | -$76.5M | -$17.4M |
| Net income | -$73.1M | -$396.1M | -$168.7M | -$73.9M | $40.0M | -$2.9M |
| Diluted EPS | -$0.21 | -$1.07 | -$0.45 | -$0.19 | $0.11 | -$0.02 |
| Operating cash flow | -$144.9M | -$153.6M | -$88.9M | -$42.8M | $18.8M | $25.9M |
| Free cash flow | -$176.3M | -$164.8M | -$92.4M | -$45.3M | $6.4M | $149,000.00 |
| Gross margin | -55.3% | -27.3% | 17.8% | 13.7% | 21.4% | 42.8% |
| Operating margin | -469.6% | -452.2% | -128.4% | -97.2% | -65.1% | -11.9% |
| Net margin | -156.5% | -613.5% | -194.5% | -84.7% | 34.0% | -2.0% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $27.8M | $34.3M | $30.3M | $32.3M | $33.5M | $36.3M | $44.5M | $45.2M |
| Gross profit | $6.3M | $3.6M | $10.8M | $13.7M | $14.5M | $18.3M | $16.2M | $19.2M |
| Operating income | -$15.6M | -$33.7M | -$11.4M | -$4.1M | -$5.3M | -$503,000.00 | -$7.5M | -$1.8M |
| Net income | -$8.8M | $8.3M | $42.6M | $6.1M | -$39.7M | $26.0M | $4.7M | $13.8M |
| Diluted EPS | -$0.02 | $0.02 | $0.12 | $0.02 | -$0.10 | $0.07 | -$0.01 | $0.04 |
| Operating cash flow | $1.7M | $11.6M | $7.7M | -$2.1M | $2.8M | $13.3M | $11.8M | $10.9M |
| Free cash flow | $1.0M | $5.2M | $4.2M | -$17.4M | -$1.0M | $8.8M | $9.7M | $9.0M |
| Gross margin | 22.7% | 10.5% | 35.7% | 42.6% | 43.4% | 50.4% | 36.4% | 42.4% |
| Operating margin | -56.1% | -98.2% | -37.5% | -12.6% | -15.9% | -1.4% | -16.8% | -4.1% |
| Net margin | -31.5% | 24.4% | 140.8% | 19.0% | -118.7% | 71.4% | 10.6% | 30.4% |
Company news
Jul 2, 2026
Jun 24, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-12 | Buggy Shannon· See Remarks | Tax withholding | 9,179 | $2.75 | $25,242.25 | filing |
| 2026-05-12 | Doucet Terrence Gregory Joseph· See Remarks | Tax withholding | 5,199 | $3.75 | $19,496.25 | filing |
| 2026-05-12 | Kenost Jared Matthew· See Remarks | Tax withholding | 3,701 | $2.75 | $10,177.75 | filing |
| 2026-05-12 | Kenost Jared Matthew· See Remarks | Option exercise | 9,412 | $0.00 | $0.00 | filing |
| 2026-05-12 | Doucet Terrence Gregory Joseph· See Remarks | Option exercise | 10,597 | $0.00 | $0.00 | filing |
| 2026-05-12 | Wagner Adam· See remarks | Option exercise | 10,367 | $0.00 | $0.00 | filing |
| 2026-05-12 | Buggy Shannon· See Remarks | Option exercise | 20,622 | $0.00 | $0.00 | filing |
| 2026-05-10 | Kenost Jared Matthew· See Remarks | Tax withholding | 2,896 | $2.54 | $7,355.84 | filing |
| 2026-05-10 | Kenost Jared Matthew· See Remarks | Tax withholding | 1,878 | $2.54 | $4,770.12 | filing |
| 2026-05-10 | Kenost Jared Matthew· See Remarks | Option exercise | 5,114 | $0.00 | $0.00 | filing |
| 2026-05-10 | Kenost Jared Matthew· See Remarks | Option exercise | 7,535 | $0.00 | $0.00 | filing |
| 2026-05-10 | Wagner Adam· See remarks | Option exercise | 10,063 | $0.00 | $0.00 | filing |
| 2026-05-10 | Wagner Adam· See remarks | Option exercise | 10,407 | $0.00 | $0.00 | filing |
| 2026-05-10 | Weigensberg Arye· See Remarks | Option exercise | 3,118 | $0.00 | $0.00 | filing |
| 2026-03-19 | Shlimak Anna· See Remarks | Tax withholding | 9,767 | $2.54 | $24,808.18 | filing |
| 2026-03-19 | Shlimak Anna· See Remarks | Option exercise | 28,429 | $0.00 | $0.00 | filing |
| 2026-03-15 | GORENSTEIN MICHAEL RYAN· See remarks below | Tax withholding | 127,706 | $2.50 | $319,265.00 | filing |
| 2026-03-15 | JACOBSON JEFFREY DAVID· Chief Growth Officer | Tax withholding | 22,552 | $2.50 | $56,380.00 | filing |
| 2026-03-15 | Doucet Terrence Gregory Joseph· See Remarks | Tax withholding | 12,276 | $3.44 | $42,229.44 | filing |
| 2026-03-15 | Shlimak Anna· See Remarks | Tax withholding | 16,354 | $2.50 | $40,885.00 | filing |
| 2026-03-15 | Buggy Shannon· See Remarks | Tax withholding | 9,202 | $2.50 | $23,005.00 | filing |
| 2026-03-15 | Shlimak Anna· See Remarks | Option exercise | 45,226 | $0.00 | $0.00 | filing |
| 2026-03-15 | GORENSTEIN MICHAEL RYAN· See remarks below | Option exercise | 324,540 | $0.00 | $0.00 | filing |
| 2026-03-15 | JACOBSON JEFFREY DAVID· Chief Growth Officer | Option exercise | 59,191 | $0.00 | $0.00 | filing |
| 2026-03-15 | Weigensberg Arye· See Remarks | Option exercise | 24,236 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.